| J David Bane, MD | |
|
3725 W 4100 South, West Valley City, UT 84120 | |
| (801) 965-3600 | |
| (801) 965-3526 |
| Full Name | J David Bane |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 3725 W 4100 South, West Valley City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477584837 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 1549951205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| J David Bane, MD 3725 W 4100 South, West Valley City, UT 84120 Ph: (801) 965-3600 | J David Bane, MD 3725 W 4100 South, West Valley City, UT 84120 Ph: (801) 965-3600 |
News Archive
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
As part of its "Young people's sexual health matters" series, the Guardian reports on a recent roundtable discussion hosted by the newspaper, in association with the International Planned Parenthood Federation (IPPF), during which experts discussed key family planning issues ahead of the July 11 London Summit.
Black children have significantly higher rates of shellfish and fish allergies than White children, in addition to having higher odds of wheat allergy, suggesting that race may play an important role in how children are affected by food allergies, researchers at Ann & Robert H. Lurie Children's Hospital of Chicago, Rush University Medical Center and two other hospitals have found.
Biovista Inc. today announced that BVA-201, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-201 is an existing drug that Biovista repositioned in MS and is aimed at neuroprotection. It was shown to have both efficacy in reducing symptoms and no toxic effects in this well established model of MS.
› Verified 5 days ago
Dr. Warren R Stack, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3540 S 4000 W, 350, West Valley City, UT 84120 Phone: 801-968-8692 Fax: 801-968-9632 | |
James Russell Grua, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3600 | |
Dr. John Erikson Yap, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3535 S Market St, West Valley City, UT 84119 Phone: 385-430-1431 | |
Kenneth Schaecher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 | |
Charles W Haws, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3725 W 4100 S, Suite 201, West Valley City, UT 84120 Phone: 801-676-3776 Fax: 801-676-0987 | |
David Oelsner, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3600 |